Quinoline-3-carboxamides modulate primary T cell-dependent B cell responses but do not inhibit functional immunity.
E Källberg, F Ivars, T Leanderson
Index: Scand. J. Immunol. 79(4) , 237-43, (2014)
Full Text: HTML
Abstract
The effect of a quinoline-3-carboxamide on the T cell-dependent B cell response was investigated in C57BL/6 mice after NP-CGG immunization. The primary serum response to the hapten was slightly inhibited by treatment with a quinoline-3-carboxamide. This inhibition was paralleled by reduced numbers of germinal centre (GC) B cells and follicular T cells in the spleen up to 21 days after immunization. Also, both the number of GCs formed and their size were reduced by quinoline-3-carboxamide treatment. In contrast to the observation in the primary immune response, there was no inhibitory effect on the secondary immune response. These data could help to explain how quinoline-3-carboxamides can modulate immune function in autoimmune diseases without being immunosuppressive.© 2014 John Wiley & Sons Ltd.
Related Compounds
Related Articles:
2014-04-01
[J. Immunol. 192(7) , 3166-79, (2014)]
2010-07-01
[J. Immunol. 185(1) , 294-301, (2010)]
2010-07-01
[Eur. J. Immunol. 40(7) , 1884-9, (2010)]
2011-12-01
[Eur. J. Immunol. 41(12) , 3506-12, (2011)]
2008-09-01
[J. Bacteriol. 190(18) , 6170-7, (2008)]